3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile
C28H15N3 — CID 121329042
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile
3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile (PubChem CID 121329042) has the molecular formula C28H15N3 and a molecular weight of 393.45 g/mol. Its IUPAC name is 3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile.
Molecular Properties
| Compound Name | 3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile |
|---|---|
| PubChem CID | 121329042 |
| Molecular Formula | C28H15N3 |
| Molecular Weight | 393.45 g/mol |
| Exact Mass | 393.13 |
| IUPAC Name | 3-(12-azapentacyclo[11.8.0.02,11.03,8.016,21]henicosa-1(13),2(11),3,5,7,9,14,16,18,20-decaen-12-yl)benzene-1,2-dicarbonitrile |
| SMILES | N#Cc1cccc(-n2c3ccc4ccccc4c3c3c4ccccc4ccc32)c1C#N |
| InChI | InChI=1S/C28H15N3/c29-16-20-8-5-11-24(23(20)17-30)31-25-14-12-18-6-1-3-9-21(18)27(25)28-22-10-4-2-7-19(22)13-15-26(28)31/h1-15H |
| InChIKey | AQTAQNZSJWRDEQ-UHFFFAOYSA-N |
| XLogP | 6.83 |
| TPSA | 52.51 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 393.45 |
| LogP ≤ 5 | 6.83 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121329042 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.